GlassScriptPhysician profile
Papiya Kakani
NPI 1326671728
$573.23
in general payments reported to CMS, 2019-2025
14 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.47 · 2024: $51.80 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $109.79 | 2025 | |
| Boston Scientific Corporation | $100.19 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $55.01 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $49.23 | 2025 | Repatha |
| Lilly USA, LLC | $45.22 | 2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $38.63 | 2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $37.47 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $23.74 | 2025 | Wainua |
| Impulse Dynamics (USA) INC. | $22.77 | 2025 | Optimizer |
| Pfizer INC. | $22.07 | 2025 | |
| Abbvie INC. | $20.91 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.38 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.04 | 2025 | Eliquis |
| Dexcom, INC. | $13.78 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Papiya Kakani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.